ALUR
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Allurion announced initial results on combining the Allurion program with low-dose tirzepatide to optimize muscle mass and GLP-1 adherenceNov 26, 2025
- Allurion passes critical FDA milestones, enters into transaction to exchange all outstanding debt resulting in company being debt-free, and announces $5 million private placement financingNov 11, 2025
- Allurion submits PMA to FDA and additional analyses from pivotal AUDACITY study meet both endpointsJul 10, 2025
- Allurion presents data on increasing muscle mass and decreasing fat mass in patients treated with its programMay 28, 2025
- Allurion to Report Q4 2024 Financial Results on March 26, 2025Mar 12, 2025